Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect
@article{Pioro2010DextromethorphanPU, title={Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect}, author={E. Pioro and B. Brooks and J. Cummings and R. Schiffer and R. Thisted and D. Wynn and A. Hepner and R. Kaye}, journal={Annals of Neurology}, year={2010}, volume={68} }
To evaluate dextromethorphan combined with ultra low‐dose quinidine (DMq) for treating pseudobulbar affect (PBA) in patients with amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Topics from this paper
Paper Mentions
News Article
Interventional Clinical Trial
The primary objective of this study is to test the hypothesis that Nuedexta (20/10)
administered orally will reduce Pseudobulbar Affect (PBA) frequency and severity
(CNS-Lability… Expand
Conditions | Alzheimer's Disease, Pseudobulbar Affect (PBA) |
---|---|
Intervention | Drug |
Interventional Clinical Trial
Objectives of the study are to evaluate the safety, tolerability, and efficacy of two
different doses of AVP-923 (capsules containing either 30 mg of dextromethorphan hydrobromide… Expand
Conditions | Pseudobulbar Affect (PBA) |
---|---|
Intervention | Drug |
143 Citations
Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial
- Medicine
- PM & R : the journal of injury, function, and rehabilitation
- 2018
- 2
- Highly Influenced
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM‐II Open Label Study
- Medicine
- PM & R : the journal of injury, function, and rehabilitation
- 2018
- 7
- Highly Influenced
- PDF
Dextromethorphan/quinidine for pseudobulbar affect associated with subarachnoid hemorrhage
- Medicine
- 2014
Pharmacotherapeutic management of pseudobulbar affect.
- Medicine
- The American journal of managed care
- 2017
- 3
- PDF
Dextromethorphan/Quinidine: A Review of Its Use in Adults with Pseudobulbar Affect
- Medicine
- Drugs
- 2014
- 23
- Highly Influenced
Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
- Medicine
- The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists
- 2014
- 6
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®) for Pseudobulbar Affect
- Medicine
- Neurology and Therapy
- 2014
- 21
- PDF
References
SHOWING 1-10 OF 43 REFERENCES
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis
- Medicine
- Annals of neurology
- 2006
- 151
Dextromethorphan: Enhancing its systemic availability by way of low‐dose quinidine‐mediated inhibition of cytochrome P4502D6
- Chemistry, Medicine
- Clinical pharmacology and therapeutics
- 1992
- 91
- Highly Influential
Sertraline in stroke‐associated lability of mood
- Psychology, Medicine
- International journal of geriatric psychiatry
- 1999
- 108
Review of pseudobulbar affect including a novel and potential therapy.
- Medicine
- The Journal of neuropsychiatry and clinical neurosciences
- 2005
- 105
- PDF
Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity
- Chemistry, Medicine
- Brain Research
- 1987
- 166
Treatment of pathologic laughing and weeping with amitriptyline.
- Medicine
- The New England journal of medicine
- 1985
- 180
Paroxetine versus citalopram treatment of pathological crying after brain injury.
- Psychology, Medicine
- Brain injury
- 1999
- 106